2m 2m 2m 2m 2m 2m 2m
RAPPORT THERA (RAPP)
NASDAQ
$41.10+$0.12 (+0.28%)
Price as of Aug 03, 2026 2:05 PM EDT- $2.0BMarket Cap
- 189.61%1-Year Change
- BiotechnologyIndustry
RAPPORT THERA (RAPP)
$41.10+$0.12 (+0.28%)
RAPP | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $40.98 | ||
Change | -$1.80 (-4.21%) | ||
Open | $42.88 | ||
High | $42.88 | ||
Low | $40.64 | ||
Previous Close | $42.78 | ||
Volume | 240,878 | ||
30-Day Average Volume | 367,035 | ||
1-Week Change | 0.74% | ||
1-Month Change | -1.66% | ||
1-Year Change | 189.61% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 47.8M | ||
Total Assets | $497.6M | ||
Market Cap | $2.0B | ||
Enterprise Value | $1.9B | ||
Period: QTR TTM FY | |||
Revenue | $20.0M | ||
Net Income | -$19.9M | ||
Free Cash Flow | -$13.1M | ||
EBIT | -$19.9M | ||
EBITDA | -$19.6M | ||
Net Working Capital | $466.8M | ||
EPS | -$0.42 | ||
Enterprise Value/EBITDA | -96 | ||
Enterprise Value/Revenue | 94 | ||
P/B | 4 | ||
P/E | -98 | ||
PEG | -2 | ||
Price/Free Cash Flow | -149 | ||
Price/Operating Cash Flow | -150 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue